| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/14/2004 | EP1379628A2 Kinases and phosphatases sequences, and use thereof |
| 01/14/2004 | EP1379557A2 Use of cd25 binding molecules in steroid-resistant patients |
| 01/14/2004 | EP1379550A2 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 01/14/2004 | EP1379528A1 Pyrazolopyrimidines as therapeutic agents |
| 01/14/2004 | EP1379524A2 Chromane derivatives, process for their preparation and their use as antitumor agents |
| 01/14/2004 | EP1379523A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 01/14/2004 | EP1379519A1 Pyrrolidine sulfonamides |
| 01/14/2004 | EP1379516A1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists |
| 01/14/2004 | EP1379507A1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS |
| 01/14/2004 | EP1379504A1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors |
| 01/14/2004 | EP1379503A1 Pyrrolidine sulfonamides |
| 01/14/2004 | EP1379495A2 Ligands of the alpha-v-beta 6 integrin |
| 01/14/2004 | EP1379492A1 Inhibitor of monoamine uptake |
| 01/14/2004 | EP1379275A2 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses |
| 01/14/2004 | EP1379265A2 Short bioactive peptides and methods for their use |
| 01/14/2004 | EP1379256A1 Method for the prevention of tissue elastic fiber injury |
| 01/14/2004 | EP1379246A1 Nociceptin analogs |
| 01/14/2004 | EP1379237A2 Pyrrolidine sulfonamides |
| 01/14/2004 | EP1379230A1 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions |
| 01/14/2004 | EP1379225A2 Novel medicament compositions based on anticholinergic agents and endothelin antagonists |
| 01/14/2004 | EP1379224A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 01/14/2004 | EP1379221A2 Pharmaceutical product with reticulated crystalline microstructure |
| 01/14/2004 | EP1379220A2 Inhalation capsules |
| 01/14/2004 | EP1379207A1 Composition for freshening nostrils and sinus cavities |
| 01/14/2004 | EP1379125A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 01/14/2004 | EP1222195B1 Novel thiazolo(4,5-d)pyrimidine compounds |
| 01/14/2004 | EP1212292B1 (-)-verbenone derivatives |
| 01/14/2004 | EP1009394B1 New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising formoterol |
| 01/14/2004 | CN1468307A Anti-dual integrin antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468305A Modulation of the transcription of pro-inflammatory gene products |
| 01/14/2004 | CN1468253A 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 01/14/2004 | CN1468252A 6.alpha., 9.alpha.-difluoro-17.alpha.-[(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 01/14/2004 | CN1468247A Ethers of 7-desmethylrapamycin |
| 01/14/2004 | CN1468246A Hydroxyesters of 7-desmethylrapamycin |
| 01/14/2004 | CN1468242A Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 01/14/2004 | CN1468239A Substituted pyrazoles |
| 01/14/2004 | CN1468238A Substituted pyrazoles |
| 01/14/2004 | CN1468237A Substituted pyrazoles |
| 01/14/2004 | CN1468236A Novel anticholinergic agents that can be used as medicaments and method for the production thereof |
| 01/14/2004 | CN1468227A Non-imidazole aryloxyalkylamines |
| 01/14/2004 | CN1468226A Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 01/14/2004 | CN1468222A N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr3 receptor antagonists |
| 01/14/2004 | CN1468221A Non-imidazole aryloxypiperidines |
| 01/14/2004 | CN1468219A Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 01/14/2004 | CN1468207A New retinoids for the treatment of emphysema |
| 01/14/2004 | CN1468094A New pharmaceutical compositions containing epinastine and pseudoephedrine |
| 01/14/2004 | CN1466996A Human SARS coronary virus receptor inhibitor |
| 01/14/2004 | CN1466987A Medicine for preventing SARS and influenza-propolis lozenge and complement synergy medicine |
| 01/14/2004 | CN1466975A Chinese traditional medicine for treating and preventing asthma in children |
| 01/14/2004 | CN1466968A Chinese herbal medicine for treating rhinitis |
| 01/14/2004 | CN1134442C Pyrazolopyrimidinone cGMPPDE 5 inhibitors, method for preparing the same and uses and intermediate |
| 01/14/2004 | CN1134420C Novel substituted imidazole compounds |
| 01/14/2004 | CN1134414C Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 01/14/2004 | CN1134260C Method of treatment for lung diseases using antisense oligonucleotides |
| 01/13/2004 | US6677373 Polymorphic B form of 3-(cyclopropylmethoxy)-4-[4-(methylsulfonyl)phenyl]-5,5-dimethyl-5H-furan-2-one |
| 01/13/2004 | US6677372 N-(3-benzofuranyl)urea-derivatives |
| 01/13/2004 | US6677368 4-aryl substituted indolinones |
| 01/13/2004 | US6677365 Antagonists of MCP-1 function and methods of use thereof |
| 01/13/2004 | US6677354 Treating sleep, brain, sexual, cardiovascular, nervous system, psychological, glandular, and gastrointestinal disorders |
| 01/13/2004 | US6677351 Useful in treatment of asthma and inflammation |
| 01/13/2004 | US6677344 Chymase inhibitor for the treatment of eosinophilia |
| 01/13/2004 | US6677340 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/13/2004 | US6677339 S-3-(4-(3,5-dichloropyrid-4-ylcarboxamido)phenyl)-2-(4,6-dimet hoxy-1,3,5-triazin-2-ylamino)propanoic acid for example; inhibit binding of alpha 4 integrins to their ligands, for treating immune or inflammatory disorders |
| 01/13/2004 | US6677316 Adenosine derivatives and methods of administration |
| 01/13/2004 | US6677153 Antisense antibacterial method and composition |
| 01/13/2004 | US6677127 Nucleic acid respiratory syncytial virus vaccines |
| 01/13/2004 | US6676939 Methods of modulating IL-174 response |
| 01/13/2004 | CA2172726C A1 adenosine receptor antagonists |
| 01/08/2004 | WO2004003235A2 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 01/08/2004 | WO2004003164A2 Methods of organ regeneration |
| 01/08/2004 | WO2004002964A1 Diaminopyrimidinecarboxa mide derivative |
| 01/08/2004 | WO2004002962A1 Novel benzimidazol-2-one derivatives and their use |
| 01/08/2004 | WO2004002961A1 Caspase inhibitors and uses thereof |
| 01/08/2004 | WO2004002948A1 Amide compound and medicinal use thereof |
| 01/08/2004 | WO2004002535A1 Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis |
| 01/08/2004 | WO2004002533A1 Stable liquid parenteral parecoxib formulation |
| 01/08/2004 | WO2004002530A1 Remedy for chronic disease |
| 01/08/2004 | WO2004002517A1 Diagnostics/preventives/re medies for respiratory diseases |
| 01/08/2004 | WO2004002516A1 Diagnostics/preventives/re medies for respiratory diseases |
| 01/08/2004 | WO2004002515A1 Diagnostics/preventives/remedies for respiratory diseases |
| 01/08/2004 | WO2004002501A1 Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy |
| 01/08/2004 | WO2004002489A1 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating pulmonary fibrosis |
| 01/08/2004 | WO2004002484A1 Phosphodiesterase inhibitor |
| 01/08/2004 | WO2004002455A1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 01/08/2004 | WO2004002424A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | WO2004002420A2 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use |
| 01/08/2004 | WO2004002418A2 Compositions and methods comprising protein activated receptor antagonists |
| 01/08/2004 | WO2003091387A3 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 01/08/2004 | WO2003090912A9 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 01/08/2004 | WO2003070166A3 Novel tyloindicines and related processes, pharmaceutical compositions and methods |
| 01/08/2004 | WO2003068812A3 Immune-modulating peptide made of s. aureus enterotoxin b |
| 01/08/2004 | WO2002095067A3 INTERFERON α-14 POLYMORPHISM |
| 01/08/2004 | WO2002092075A3 Therapeutic delivery of carbon monoxide |
| 01/08/2004 | WO2002079448A3 G-protein coupled receptors |
| 01/08/2004 | WO2002068650B1 Modified and stabilized gdf propeptides and uses thereof |
| 01/08/2004 | WO2002048397A3 Regulation of human adenylate cyclase, type vii |
| 01/08/2004 | WO2002046225A3 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 01/08/2004 | US20040006373 Method and device for treating osteoarthritis, cartilage disease, defects and injuries in the human knee |
| 01/08/2004 | US20040006242 Immunomodulatory compounds and method of use thereof |
| 01/08/2004 | US20040006224 Synthesis of 2-alkyl amino acids |